Key result
Angiotensin converting enzyme (ACE) and its regulated peptide network, including angiotensin II, substance P, Ac-SDKP, and angiotensin 1-7, play active roles in orchestrating hematopoiesis.
This review highlights the emerging role of the local bone marrow renin-angiotensin system and ACE-regulated peptides in hematopoiesis, identifying ACE as a marker for hematopoietic stem cells.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for bone marrow RAS effects on hematopoiesis; leaves open clinical relevance of ACE modulation in patients.
The concept of a local bone marrow renin-angiotensin system (RAS) has been introduced and accumulating evidence suggests that the local RAS is actively involved in hematopoiesis. Angiotensin converting enzyme (ACE) is a key player in the RAS and makes the final effector angiotensin II. Besides angiotensin II, ACE also regulates a panel of bioactive peptides, such as substance P, Ac-SDKP and angiotensin 1-7. These peptides have also been individually reported in the regulation of pathways of hematopoiesis. In this setting, an ACE-regulated peptide network orchestrating hematopoiesis has emerged. Here, we focus on this peptide network and discuss the roles of ACE and its peptides in aspects of hematopoiesis. Special attention is given to the recent revelation that ACE is a bona fide marker of hematopoietic stem cells.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2011) conducted a review in Hematopoiesis. ACE and its regulated peptides was evaluated. Angiotensin converting enzyme (ACE) and its regulated peptide network, including angiotensin II, substance P, Ac-SDKP, and angiotensin 1-7, play active roles in orchestrating hematopoiesis.
Synapse has enriched 10 related papers. Consider them for comparative context: